Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability ...

The altcoin rally may only be getting started and follows the signing of the GENIUS Act, the most significant U.S. crypto ...

Shares of Galaxy Digital Inc. (NASDAQ: GLXY) are trading higher Monday after the company announced a partnership with K Wave ...

Wayfair (NYSE: W) expected to beat Street estimates for Q2 sales and profitability. Analyst raises estimates, sees potential ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.